In both the study groups (Phase 1 and Phase 2), the group of patients showing reduced PRL level in the subsequent samples exhibited significantly high PSS score compared to the group of patients who did not exhibit any reduction in the serum PRL level (either increased or remained same) in the subsequent samples, indicating the possibility of stress-induced hyperprolactinemia. The gene discussed is PRL; the disease is hyperprolactinemia.